2nd International Conference on Fostering Interdisciplinary Research In Health Sciences (ICFIRHS) 2019 (01-May-2019)        |

Journal :   Research Journal of Pharmacy and Technology

Volume No. :   11

Issue No. :  11

Year :  2018

Pages :   4965-4970

ISSN Print :  0974-3618

ISSN Online :  0974-360X


Registration

Allready Registrered
Click to Login

Evidence based Evaluation of Antidiabetic Potential of Yesaka on Streptozotocin Diabetic Rats



Address:   Nitin D Deore1, Shruti Gupta*3,4, Birendra Shrivastav1, C. D. Upasni2, Kishori G Apte3 , Shaikh A. M5
1School of Pharmaceutical Sciences, Jaipur National University, Jaipur, Rajasthan.
2SNJB's Shriman Sureshdada College of Pharmacy, Nashik, Maharashtra.
3APT Research Foundation, Pune, India.
4Faculty of Health and Biomedical Sciences, Symbiosis International University, Pune, India.
5AAEMF’S Delight College of Pharmacy, Pune.
*Corresponding Author
DOI No: 10.5958/0974-360X.2018.00904.6

ABSTRACT:
Yesaka is a known Ayurvedic polyherbal formulation, traditionally employed in the treatment of diabetes mellitus. The current study was performed to evaluate the antidiabetic activity of Yesaka. Antihyperglycemic effects of Yesaka and glipizide were demonstrated in high fat diet-streptozotocin induced diabetic rats. Diabetes was induced by feeding Sprague Dawley rats with high-fat diet (HFD) for two months followed by a single dose of Streptozotocin (STZ, 30mg/kg intraperitoneally). The animals were grouped under normal control and six diabetic subgroups (n=6). All the diabetic rats were orally treated with glipizide as standard (5mg/kg), Yesaka (1.8ml/kg and 3.6ml/kg) and with combination of Yesaka and standard for 4 weeks. The results were assessed by significant restoration of bodyweight, reduction in plasma glucose, total cholesterol (TC), triglycerides (TG), low density lipoprotein-cholesterol (LDL-C) while increased high density lipoprotein cholesterol (HDL-C) levels in all the treatment groups compared to diabetic animals. The antioxidant activity of Yesaka was also evaluated by DPPH. Thus, these findings demonstrated the antidiabetic potential of Yesaka in HFD-fed STZ-treated diabetic rats along with glipizide. Thus, may be a promising candidate in the treatment and management of diabetes with strong antioxidant potential.
KEYWORDS:
Diabetes mellitus, antihyperglycemic, insulin, hyperglycemic, streptozotocin.
Cite:
Nitin D Deore, Shruti Gupta, Birendra Shrivastav, C. D. Upasni, Kishori G Apte , Shaikh A. M. Evidence based Evaluation of Antidiabetic Potential of Yesaka on Streptozotocin Diabetic Rats. Research J. Pharm. and Tech 2018; 11(11): 4965-4970.
[View HTML]     



Visitor's No. :   544926